OpenAlex
PricingAboutJobs
Log inGet started
Work

The mTOR inhibitor everolimus in combination with carboplatin in metastatic breast cancer--a phase I trial.

PubMed

Year: 2012
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Sandra Schwarzlose-Schwarck, Christian W Scholz, Anne C Regierer, Peter Martus, Christian Neumann, Piet Habbel, Hongyu Liu, Chuanbing Zang, Jan-Hendrik Schefe, Carsten-Oliver Schulz, Kurt Possinger, Jan Eucker
Institution: Charité – Universitätsmedizin Berlin
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: everolimus, carboplatin, metastatic breast cancer, mTOR inhibitors, combination chemotherapy, maximum tolerated dose, dose-limiting toxicity, heavily pretreated patients
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2105717610
FWCI: 1.621
Cites: 32
Cited by: 22
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security